---
document_datetime: 2024-08-02 12:33:40
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/apexelsin-epar-all-authorised-presentations_en.pdf
document_name: apexelsin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.684415
conversion_datetime: 2025-12-22 16:51:17.823101
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form                | Route of administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/24/1835/001 | Apexelsin         | 5mg/ml     | Powder for dispersion for infusion | Intravenous use           | vial (glass)          | 100 mg                    | 1 vial      |